OMAHA, Neb., May 7 /PRNewswire-FirstCall/ -- Transgenomic Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:

        What:     Transgenomic Inc. First Quarter 2009 Earnings Release
                   Conference Call
        When:     Wednesday, May 13, 2009 @ 5:00 p.m. Eastern
        Where:    http://www.transgenomic.com/events.asp?id=6
        How:      Live over the Internet -- Simply log on to the web at
                   the address above.
        Contact:  Investor Relations, 402-452-5400

To access the call via telephone, call 800-895-0231 or 785-424-1054. A replay of the call will be available via telephone until 11:59 pm ET on Wednesday, May 27, 2009. To access, dial 800-723-0544 or 402-220-2656.

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Molecular Clinical Reference Laboratory and Pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: www.transgenomic.com.

SOURCE Transgenomic, Inc.